Tokai Pharmaceuticals Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
- Investors
-
1
Tokai Pharmaceuticals General Information
Description
Novus Therapeutics Inc is engaged in the biotechnology sector. As a pharmaceutical company, it is focused on the acquisition, development, and commercialization of ear, nose, and throat related products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP-02 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction.
Contact Information
Website
www.tokaipharmaceuticals.comCorporate Office
- 255 State Street
- 6th Floor
- Boston, MA 02109
- United States
Corporate Office
- 255 State Street
- 6th Floor
- Boston, MA 02109
- United States
Tokai Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 10-May-2017 | Completed | Generating Revenue | |||
| 10. PIPE | 17-Sep-2014 | Completed | Clinical Trials - Phase 3 | |||
| 9. IPO | 17-Sep-2014 | Completed | Clinical Trials - Phase 3 | |||
| 8. Later Stage VC (Series E) | 15-May-2013 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series D3) | 20-Sep-2011 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D2) | 08-May-2009 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D1) | Completed | Generating Revenue | ||||
| 4. Later Stage VC (Series C) | Completed | Generating Revenue | ||||
| 3. Early Stage VC (Series B2) | 21-Oct-2008 | $6.56M | $11.5M | Completed | Startup | |
| 2. Early Stage VC (Series B1) | 07-Jun-2007 | $2.7M | $4.95M | Completed | Startup |
Tokai Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D3 | ||||||||
| Series D2 | ||||||||
| Series D1 | ||||||||
| Series C | ||||||||
| Series B2 | ||||||||
| Series B1 | 798,067 | $0.001000 | 8% | $3.38 | $3.38 | 1x | $3.38 | 0.5% |
| Series A | 4,500,000 | $0.001000 | 8% | $0.5 | $0.5 | 1x | $0.5 | 2.8% |
Tokai Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Tokai Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tokai Pharmaceuticals Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Novartis Venture Fund | Corporate Venture Capital | Minority | ||
| Novo Holdings | Venture Capital | Minority | ||
| Pontifax Venture Capital | Venture Capital | Minority | ||
| QIC BioVentures | Venture Capital | Minority | ||
| Vivo Capital | Venture Capital | Minority |
Tokai Pharmaceuticals Acquisitions (1)
Tokai Pharmaceuticals’s most recent deal was a Reverse Merger with Eledon Pharmaceuticals. The deal was made on 09-May-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Eledon Pharmaceuticals | 09-May-2017 | Reverse Merger | Other Pharmaceuticals and Biotechnology |
Tokai Pharmaceuticals FAQs
-
When was Tokai Pharmaceuticals founded?
Tokai Pharmaceuticals was founded in 2004.
-
Where is Tokai Pharmaceuticals headquartered?
Tokai Pharmaceuticals is headquartered in Boston, MA.
-
What is the size of Tokai Pharmaceuticals?
Tokai Pharmaceuticals has 10 total employees.
-
What industry is Tokai Pharmaceuticals in?
Tokai Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Tokai Pharmaceuticals a private or public company?
Tokai Pharmaceuticals is a Private company.
-
What is Tokai Pharmaceuticals’s current revenue?
The current revenue for Tokai Pharmaceuticals is .
-
How much funding has Tokai Pharmaceuticals raised over time?
Tokai Pharmaceuticals has raised $190M.
-
Who are Tokai Pharmaceuticals’s investors?
Novartis Venture Fund, Novo Holdings, Pontifax Venture Capital, QIC BioVentures, and Vivo Capital have invested in Tokai Pharmaceuticals.
-
When was Tokai Pharmaceuticals acquired?
Tokai Pharmaceuticals was acquired on 10-May-2017.
-
Who acquired Tokai Pharmaceuticals?
Tokai Pharmaceuticals was acquired by Eledon Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
